About

EMDrugs was created and is maintained by emergency physicians to improve practice standards and support clinical decision-making in emergency care. It was founded in 2021 as a specialized resource focused on medications used in emergency care.

All content is written and edited by specialist emergency physicians, in collaboration with other healthcare professionals.
EMDrugs is designed as a point-of-care tool for emergency physicians and trainees, clinical pharmacologists, general practitioners, physician assistants, nurse practitioners, and other professionals involved in emergency care.

What you will find

Induction agents and neuromuscular blocking agents
Pain pharmacotherapy
Vasopressors
Fibrinolytic therapy
Antiepileptic drugs, and more

Our Team

Cristóbal Sáa, MD — Founder, Editor-in-Chief
Juan Ignacio Sáa — Co-Founder, CTO
Joaquín Chuecas, MD — Content, Toxicology Advisor
Olenhka Cepeda — Scientific Archivist

Acknowledgements

We are grateful to everyone who has contributed to EMDrugs with their knowledge, work, and dedication. A special thanks goes to our co-founders, José Pedro Sepúlveda, MD (former content writer), and Fernando Segura, MD (former COO).

We also thank Giancarlo Zuccone, MD; Benjamín Donoso, MD; David Díaz, MD; and Jerónimo Rojas, MD for their pharmacological writing; Sergio Sepúlveda for his work during his coding internship and continued collaboration since 2024; and Diego Schmidt for his contributions to graphic design. Finally, we thank Juan C. Rojas for language review services and Daniel Gallardo for the 2025 website design renovation.

Content integrity, AI

All scientific and pharmacological content is written by licensed physicians based on independent reviews of the medical literature. Artificial intelligence and language model tools are used only for orthographic and grammatical support.

Get started

Activated charcoal (Open access)

Amiodarone (Open access)

Inductors (Open access)